المؤلفون: Burr NE; Section of Molecular Gastroenterology, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, LS9 7TF, UK, n.burr@leedsth.nhs.uk., Talboys RJ, Savva S, Clark A, Phillips M, Metcalfe M, Dennison A, Robinson R, Lewis MP, Rhodes M, Rushbrook S, Hart AR

المصدر: Digestive diseases and sciences [Dig Dis Sci] 2014 Jul; Vol. 59 (7), pp. 1567-72. Date of Electronic Publication: 2014 Feb 18.

نوع المنشور: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE

مواضيع طبية MeSH: Bile Ducts, Intrahepatic*, Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use , Aspirin/*therapeutic use , Bile Duct Neoplasms/*prevention & control , Cholangiocarcinoma/*prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Bile Duct Neoplasms/etiology ; Case-Control Studies ; Cholangiocarcinoma/etiology ; Confidence Intervals ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Risk Factors ; United Kingdom